B6-IgG1 KO Mouse
Product Name
B6-IgG1 KO Mouse
Product ID
C001390
Strain Name
C57BL/6JCya-Ighg1em1/Cya
Backgroud
C57BL/6JCya
Status
When using this mouse strain in a publication, please cite “B6-IgG1 KO Mouse (Catalog C001390) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Strain Description
Immunoglobulin G (IgG) is the most abundant type of immunoglobulin in human serum, accounting for about 75% of the total serum immunoglobulins. It also has the longest half-life among serum immunoglobulins. IgG is synthesized in the spleen and lymph nodes and is primarily distributed in serum and tissue fluids. It is a major component of antibodies against bacteria, toxins, and viruses, and plays a crucial role in the body's immune response against infections. IgG is the only immunoglobulin that can cross the placental barrier, playing an important role in neonatal infection protection [1]. There are four IgG subtypes in the human body, with the IgG1 subtype accounting for about 66% of the total serum IgG. IgG1 is very important for mediating antibody responses against viral pathogens. It can effectively bind to C1q, triggering complement-dependent cytotoxicity (CDC), and bind to various Fc receptors, inducing antibody-dependent cell-mediated cytotoxicity (ADCC). These are two of the most important functions in immune responses. Therefore, IgG1 has always been the preferred model for antibody therapy and is the most promising subtype in tumor immunotherapy [2-3].
Selective IgG Subclass Deficiency is one of the most common immunodeficiency diseases in children. Patients with this disease have reduced total serum IgG levels, or normal total IgG levels but one or more IgG subclasses below normal levels. In most cases, patients with IgG1 deficiency also have deficiencies in other IgG subclasses, often with low serum IgG levels. Those with deficiencies in other IgG categories are prone to developing common variable immunodeficiency (CVID). Patients usually have a lifelong history of susceptibility to pyogenic infections, which can develop into chronic, progressively worsening lung infections, and commonly have deficient antibody responses to diphtheria and tetanus toxins [4-5].
The mouse Ighg1 gene is homologous to the human IGHG1, IGHG2, and IGHG3 genes. B6-IgG1 KO mice are constructed by knocking out the Ighg1 gene in mice, creating a model of IgG1 deficiency. This model provides an effective tool for research on diseases related to IgG1 deficiency.
Reference
Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014 Oct 20;5:520.
de Taeye SW, Bentlage AEH, Mebius MM, Meesters JI, Lissenberg-Thunnissen S, Falck D, Sénard T, Salehi N, Wuhrer M, Schuurman J, Labrijn AF, Rispens T, Vidarsson G. FcγR Binding and ADCC Activity of Human IgG Allotypes. Front Immunol. 2020 May 6;11:740.
Pereira NA, Chan KF, Lin PC, Song Z. The "less-is-more" in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity. MAbs. 2018 Jul;10(5):693-711.
O'Keeffe S, Finnegan P. IgG subclass deficiency. Chest. 1993 Dec;104(6):1940.
Barton JC, Barton JC, Bertoli LF, Acton RT. Factors associated with IgG levels in adults with IgG subclass deficiency. BMC Immunol. 2021 Aug 9;22(1):53.
Strain Strategy
The Ighg1 gene is located on chromosome 12 in mice. Using gene-editing technology, exons 1 to 6 of this gene have been knocked out.
Figure 1. Diagram of the gene editing strategy for the generation of B6-IgG1 KO mice.
Application Area
Research on IgG1 Deficiency Diseases；
Research on Hypogammaglobulinemia Related to IgG Deficiency；
Study of the Mechanisms and Functions of Immunoglobulin G (IgG).
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
